HOME >> MEDICINE >> NEWS
Chemists Develop Probe To Detect Changes In Imaging Agents Inside Body

organ of the animal, and make a measurement. That's how we do it."

Doctoral candidate Maria Theresa Lee has the difficult job of producing the probes which are so fragile they have to be encased in a tiny capillary of glass. "You can hardly see the fibers," remarked Lee. "It's very difficult when you're making it. You have to be careful breathing or else it just flies away."

Lee hopes her probes will lead to the development of even better imaging agents, because the probes will show radiologists what happens chemically to the imaging agent as it travels through the bloodstream. Scientists in the department of radiology in UC's College of Medicine are researching that part of the problem.

"Nobody knows exactly what happens to the compound in the body," said Lee. "It's a very harsh and complex environment, and no one knows what happens to it."

Lee presented her results from in vitro testing during the recent Pittsburgh Conference on Analytical Chemistry. She is now testing her probes on live animals in collaboration with radiology professor Anthony McGoron who presented their work at the Society of Nuclear Medicine meeting in Denver, Colorado in June. So far, the probes appear to be working well despite concerns over their stability.

"You have the heart beating and bumping, and you know how fragile the carbon fiber is. We tried it, and we didn't have any problems with it."

Professor Heineman believes the probes could eventually be used to study other medically important compounds such as brain imaging agents and kidney imaging agents, but he realizes a lot of research remains to be done.

"We've just demonstrated that we have the capability to do this, so it's opened up a frontier. We've opened the door, but we haven't taken too many steps yet."

In fact, all of the preliminary research has been done using rhenium complexes instead of technetium to avoid the difficulties of working with radioactive materials. Rhenium is chemically similar
'"/>

Contact: Chris Curran
chris.curran@uc.edu
513-556-1806
University of Cincinnati
13-Jun-1996


Page: 1 2 3

Related medicine news :

1. Chemists identify immune system mechanism for methamphetamine binges
2. Chemists synthesize molecule that helps body battle cancers, malaria
3. Chemists honor Heroes for biotechnology achievements in health
4. Chemists seek light-activated glue for vascular repair
5. Chemists create synthetic cytochromes
6. Chemists show proteins behave differently inside cells than they do in water solutions
7. Chemists take new approach to fighting resistance
8. Chemists Discover That Aerosol Clusters Play Larger Role In Generation Of Air Pollution
9. Over 6,000 Technical Presentations Will Reveal New Findings At National Chemists Meeting In Boston, August 23 - 27
10. Chemists Closing In On Commercial Potential Of Alkanes
11. Society for Research in Child Development (SRCD) biennial meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chemists Develop Probe Detect Changes Imaging Agents Inside Body

(Date:5/23/2013)... FL (PRWEB) May 23, 2013 ... regenerative medicine company focused on the commercialization of ... and regeneration, today announced that the Company and ... million grant, for which AxoGen’s portion is approximately ... administrated by the U.S. Department of Defense (DoD) ...
(Date:5/23/2013)... 2013 Hile Design LLC is pleased ... awarded a Silver Creative Award at the Summit International ... entry was for its “Open Doors” animation promoting Scio ... in the 2013 District 6 ADDY Awards for the ... Creative Award recognizes and celebrates the creative achievements of ...
(Date:5/23/2013)... Utah (PRWEB) May 23, 2013 Registered ... R.D., published an article today on Tatalou.com offering helpful ... vacation. , The article, titled “ How to Stay ... important to carry hand sanitizer, when it’s safe to ... out for seafood, the importance of staying hydrated and ...
(Date:5/23/2013)... OH and Durham, NC (PRWEB) May 23, 2013 ... and commercialization firm that funds and develops innovative ... Deep Brain Innovations, LLC (DBI). DBI will ... optimize deep brain stimulation (DBS) therapy for patients ... is effective in treating Parkinson’s disease and generates ...
(Date:5/23/2013)... Consortium, Ltd., issued the following statement today on ... Reform of chemical safety legislation will succeed only ... Ensuring the safety and appropriate use of chemicals ... Toxic Substances Control Act is a critical opportunity ... transforming toxicity testing "from a system based on ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 2Health News:AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense 3Health News:How to Stay Healthy While Traveling 2Health News:NDI Launches Deep Brain Innovations, LLC 2Health News:NDI Launches Deep Brain Innovations, LLC 3
(Date:5/22/2013)... PLAINS, N.Y. , May 22, 2013  The ... million to Valor Biotherapeutics, LLC, a joint ... of pre-clinical development, manufacturing, and a Phase I clinical ... the poor outcomes faced by many patients with indolent ... rituximab. Valor,s protein, IGN002, is a ...
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 ... presented from the DEFLECT-I study demonstrates that Keystone Heart,s ... volume during TAVR (Transcatheter Aortic Valve Replacement) procedures when ... Advisory Board announces consensus on the importance of preserving ... and need for cerebral protection during cardiovascular procedures to ...
(Date:5/22/2013)... -- For the 3% of the population that suffer from ... anxiety-inducing and disabling.  While more than half of these ... hyperhidrosis is a serious medical condition.  Finally, there is ... Dr. Bruce Katz , ... New York , is leading an ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Is There Finally A Way To Stop Severe Excessive Sweating? 2
Cached News: